Arteriosclerosis, Thrombosis, Vascular Biology
Science NewsView All Science News
06/26/2017 | This scientific statement provides an analysis of the opportunities and the challenges faced in context of the ongoing battle against car...
ATVB | PVD 2017 Scientific Sessions
Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease 2017 Scientific Sessions
May 4-6, 2017
Hyatt Regency Minneapolis
Minneapolis, Minnesota
Professional Online Network
Guidance on clopidogrel
Patient education on aspirin, other antiplatelet drugs - Read AHA news article
FDA Drug Safety Communication: FDA review finds long-term treatment with blood-thinning medicine Plavix (clopidogrel) does not change risk of death... Read More on the FDA Site (opens in new window)
Over 350,000 cardiac arrests occur outside a hospital each year in the US, with survival rates of less than 12 percent. Believe it or not, only half of Americans can be counted on to perform Hands-Only CPR in an emergency, according to an AHA Hands-Only CPR study. This month, spend one important minute preparing for those emergency situations by learning Hands-Only CPR.
heart.org/handsonlycpr
Related Councils
Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
Council on Peripheral Vascular Disease (PVD)
The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Joshua A. Beckman, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease